Search results
Added:
1 month ago
Heart Failure Association Congress 2026 — Dr Philippe Debonnaire (AZ Sint Jan, Brugge, BE) and Professor Victoria Delgado (University Hospital Germans Trias i Pujol, Badalona, SP) discuss the expanding role of advanced cardiac imaging in heart failure diagnosis and management, and what a more personalised, multimodality approach means for clinical practice.The conversation moves beyond…
View more
Added:
8 months ago
AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying hypothesis that heart failure with preserved ejection fraction arises primarily from visceral adipose tissue dysfunction and altered adipokine signaling, rather than as a heterogeneous disorder driven by multiple comorbidities.Interview Questions:Can you explain the core…
View more
Added:
1 year ago
Professor Javed Butler presents a routine case study of a HFrEF patient recently discharged from hospital for decompensated heart failure. The patient was treated with IV diuretics but now requires optimization of his on-going therapy, Professor Butler asks, ‘what should we do first?’.Follow the following links to watch further case studies on Worsening Heart Failure presented by Gianluigi…
View more
Added:
1 year ago
EASD 24 - We are joined by Professor John McMurray (University of Glasgow, UK) to discuss the key findings from a diabetes subgroup analysis of the FINEARTS-HF study.Interview Questions:1. What is the reasoning behind this analysis?2. What was the study design and patient cohort?3. What are the key findings?4. In your opinion, what can explain this risk reduction?5. What are the take-home…
View more
Added:
1 year ago
ESC 2024 - We are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.Trials covered in detail include:FINEARTS HFHELIOS-BRESHAPE HF2Recorded remotely from Los Angeles, 2024.Editors: Jordan Rance and Mirjam Boros.Videographers: Mike Knight, Dan Brent,…
View more
Added:
2 years ago
HFA 2024 — Dr Tauben Averbuch and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the findings from the PACT-HF trial. In this analysis of PACT-HF, investigators looked at long term sex-specific clinical outcomes and healthcare resource utilisation following hospitalisation for heart failure at 5 years.Findings shows that clinical outcomes and overall costs were similar between…
View more
Added:
1 year ago
Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.From addressing hyperkalaemia fears to identifying gaps…
View more
Added:
10 months ago
ESC Congress 2025 – The second day of ESC Congress 2025 brought forth significant findings with major implications for cardiovascular care.Interventional specialists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) share their expert analysis of the essential insights from the day's hot line trial presentations.Day 2 Highlights:MAPLE-HCMODYSSEY-HCMBETAMI…
View more
Added:
1 month ago
HFA Congress 2026 — Dr Rui Baptista (University of Coimbra, Coimbra, PT) joins us to discuss findings from the PORTHOS (PORTuguese Heart Failure Observational Study), a nationwide, population-based epidemiological study examining heart failure prevalence and characteristics in mainland Portugal using contemporary diagnostic tools.PORTHOS enrolled 6,189 adults aged 50 and above, randomly selected…
View more
Added:
3 months ago
Dr Purvi Parwani (Loma Linda University Health, US) recaps the standout science from Day 2 of ACC 2026, a day defined by a central theme: challenging long-held assumptions in cardiology. Her summary focuses on what these updates mean for day-to-day clinical practice, from prevention strategies to interventional decision-making.Prevention and Risk ReductionVESALIUS-CV: Showed a 25% reduction in…
View more